Stockscreener 앱 받기
3.21
1.53%
-0.05
시장 영업 전:
3.12
-0.09
-2.80%
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser
Aclarion (ACON) upgraded to buy: Here's why - MSN
ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser
ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser
Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria
Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka
Aclarion announces $2.5M stock repurchase plan - MSN
Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsSubscription Growth - newser.com
Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN
Aclarion sees net loss but strengthens cash position - BizWest
ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aclarion (NASDAQ: ACON) widens Q1 2026 loss but boosts cash with $10.4M raise - Stock Titan
Insider Move: Aclarion Director Makes Bold New Share Purchase - TipRanks
Aclarion director Scott Breidbart acquires $18,011 in stock - Investing.com
Aclarion director Scott Breidbart acquires $18,011 in stock By Investing.com - Investing.com India
Director at Aclarion (ACON) buys 5,664 Common Stock shares in public trade - Stock Titan
Aclarion director David Neal buys $7,750 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David Neal buys $7,750 in company stock - Investing.com
Aclarion (NASDAQ: ACON) director purchases 2,500 shares in open market trade - Stock Titan
TradingKey - TradingKey
Top Executive Makes Bold Insider Move at Aclarion, Inc. - TipRanks
Press Release: Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. - 富途牛牛
Aclarion (ACON) CEO makes open-market share purchase - Stock Titan
What Aclarion (ACON) is doing that smart money tracks (Momentum Building) 2026-05-08Oversold Bounce - newser.com
Aclarion (ACON) director adds 1,562 shares in open-market purchase - Stock Titan
ACONW (Aclarion WT) quarterly update shows limited financial disclosure as investors await complete earnings details.High Interest Stocks - newser.com
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial - Investing.com
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment - The Manila Times
Beverly Hills spine practice joins 300-patient back pain trial - Stock Titan
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine - Orthopedics This Week
Aclarion Grants Inducement Stock Option to New Western U.S. Commercial Director Amid Growing Demand for Nociscan - citybuzz -
Aclarion Grants Commercial Director Stock Options for 75,000 Shares - geneonline.com
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. - The Manila Times
New Western U.S. director gets 17,000-share Aclarion option - Stock Titan
Aclarion establishes second trial agreement with Weill Cornell By Investing.com - Investing.com India
0.66%
4.05%
자본화:
|
볼륨(24시간):